Cargando…

Effects of Deferasirox in Alzheimer’s Disease and Tauopathy Animal Models

The accumulation of iron may contribute to Alzheimer’s disease (AD) and other tauopathies. The iron chelator desferrioxamine slows disease progression in AD patients. However, desferrioxamine requires injection, which is inconvenient and may hinder compliance. We therefore tested an oral iron chelat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwan, Ping, Ho, Amy, Baum, Larry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945800/ https://www.ncbi.nlm.nih.gov/pubmed/35327557 http://dx.doi.org/10.3390/biom12030365

Ejemplares similares

The Effects of a Blood–Brain Barrier Penetrating Erythropoietin in a Mouse Model of Tauopathy
por: Yang, Joshua, et al.
Publicado: (2023)

Hypersensitivity reaction with deferasirox
por: Sharma, Atul, et al.
Publicado: (2015)

Comparative analysis of autophagy and tauopathy related markers in cerebral ischemia and Alzheimer’s disease animal models
por: Villamil-Ortiz, Javier G., et al.
Publicado: (2015)

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
por: Chang, Hui-Yun, et al.
Publicado: (2018)

Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major
por: Karami, Hossein, et al.
Publicado: (2017)

Positron Emission Tomography in Animal Models of Tauopathies
por: Cao, Lei, et al.
Publicado: (2022)

Magnetic Resonance Imaging in Tauopathy Animal Models
por: Ni, Ruiqing
Publicado: (2022)

Deep learning‐based model for diagnosing Alzheimer's disease and tauopathies
por: Koga, Shunsuke, et al.
Publicado: (2021)

Effects of Animal-Assisted Therapy (AAT) in Alzheimer’s Disease: A Case Study
por: Gregorini, Armando, et al.
Publicado: (2022)

Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
por: Wu, Dijiong, et al.
Publicado: (2018)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

Deferasirox: Duodenal perforation: case report
Publicado: (2021)

G-CSF rescues the memory impairment of animal models of Alzheimer's disease
por: Tsai, Kuen-Jer, et al.
Publicado: (2007)

Early Cognitive and Behavioral Deficits in Mouse Models for Tauopathy and Alzheimer’s Disease
por: Samaey, Celine, et al.
Publicado: (2019)

Rationale for the development of an Alzheimer’s disease vaccine
por: Kwan, Ping, et al.
Publicado: (2019)

Type-I Interferons in Alzheimer's Disease and Other Tauopathies
por: Sanford, Sophie A. I., et al.
Publicado: (2022)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
por: Bittar, Alice, et al.
Publicado: (2018)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

Deferasirox – a rarer cause of Fanconi syndrome
por: Khan, Iman, et al.
Publicado: (2019)

Simple model systems reveal conserved mechanisms of Alzheimer’s disease and related tauopathies
por: Jiang, Yuwei, et al.
Publicado: (2023)

Mutations in MAPT give rise to aneuploidy in animal models of tauopathy
por: Rossi, Giacomina, et al.
Publicado: (2013)

Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies
por: Tong, Benjamin Chun-Kit, et al.
Publicado: (2022)

Assessing THK523 selectivity for tau deposits in Alzheimer’s disease and non–Alzheimer’s disease tauopathies
por: Fodero-Tavoletti, Michelle T, et al.
Publicado: (2014)

DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
por: Zimmer-Bensch, Geraldine, et al.
Publicado: (2021)

Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome
por: Polat, Asude Kara, et al.
Publicado: (2017)

Ion Channel Formation by Tau Protein: Implications for Alzheimer’s Disease and Tauopathies
por: Patel, Nirav, et al.
Publicado: (2015)

Cognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy
por: Huber, Colin M., et al.
Publicado: (2017)

Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease
por: Hanseeuw, Bernard J., et al.
Publicado: (2019)

Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies
por: Castillo-Carranza, Diana L, et al.
Publicado: (2017)

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
por: Sinsky, Jakub, et al.
Publicado: (2021)

CNI-1493 inhibits Aβ production, plaque formation, and cognitive deterioration in an animal model of Alzheimer's disease
por: Bacher, Michael, et al.
Publicado: (2008)

Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease
por: Wong, Trisha E., et al.
Publicado: (2021)

Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies
por: Maschio, Cinzia, et al.
Publicado: (2022)

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
por: Trojanowski, John Q
Publicado: (2013)

The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies
por: Gonçalves, Rafaella Araujo, et al.
Publicado: (2019)

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
por: Tan, Meng-Shan, et al.
Publicado: (2021)

Deferasirox/hydroxychloroquine: Various toxicities and off-label use in coronavirus disease 2019: case report
Publicado: (2021)

Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies
por: del Campo, Marta, et al.
Publicado: (2021)

A Rapid Gene Delivery–Based Mouse Model for Early-Stage Alzheimer Disease–Type Tauopathy
por: Siman, Robert, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7r16ifijlhj0j522ofa7428rt9